• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Higher Gradient Whole-Body MRI Scanner Gets FDA Nod

News
Article

At an amplitude of 200 mT/m and a slew rate of 200 T/m/s, the gradients for the FDA-cleared MAGNETOM Cima.X are reportedly the strongest for currently available whole-body MRI scanners.

Offering a robust gradient system and a variety of workflow enhancements, the MAGNETOM Cima.X 3T whole-body magnetic resonance imaging (MRI) scanner has garnered 510(k) clearance from the Food and Drug Administration (FDA).

Siemens Healthineers, the manufacturer of the MAGNETOM Cima.X system, said the device features Gemini Gradients that have an amplitude of 200 millitesla per meter (mT/m) and a slew rate of 200 telsa per meter per second (T/m/s).

For imaging of patients with neurodegenerative diseases, the industry-leading gradient strength enhances the visibility of microstructures in the brain, according to Siemens Healthineers. The company noted that the MAGNETOM Cima.X system also features the artificial intelligence (AI)-powered Deep Resolve reconstruction technology, which can accelerate MRI brain scans by 70 percent.

Higher Gradient Whole-Body MRI Scanner Gets FDA Nod

The newly FDA-cleared, whole-body MAGNETOM Cima.X MRI system offers enhanced gradient strength that may facilitate improved visualization of brain microstructures as well as artificial intelligence (AI)-powered reconstruction technology that can accelerate MRI brain scans by 70 percent, according to Siemens Healthineers, the manufacturer of the system.

Another benefit of the whole-body MRI modality, according to Siemens Healthineers, is the capability to provide time-stamped physiological data through the system’s Physiologging feature, which enables clinicians to ascertain whether respiratory activity is compromising brain activity.

“With the FDA clearance of the MAGNETOM Cima.X, Siemens Healthineers proudly offers the scientific and medical communities a whole-body 3T MR scanner that can deliver penetrating new insights into oncologic, cardiac, and neurodegenerative disease,” noted Katie Grant, the vice president of magnetic resonance at Siemens Healthineers North America.

Recent Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.